Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 153

1.

Comparative Study of Two Cohorts of Newly Diagnosed Crohn's Disease Demonstrates Change in Therapeutic Strategies.

Icht O, Yanai H, Ron Y, Rosner G, Yaron A, Waizbard A, Ziv-Baran T, Fishman S, Dotan I.

Digestion. 2017 Aug 26;96(3):135-141. doi: 10.1159/000477438. [Epub ahead of print]

PMID:
28848118
2.

Machine Learning-Based Gene Prioritization Identifies Novel Candidate Risk Genes for Inflammatory Bowel Disease.

Isakov O, Dotan I, Ben-Shachar S.

Inflamm Bowel Dis. 2017 Sep;23(9):1516-1523. doi: 10.1097/MIB.0000000000001222.

PMID:
28795970
3.

The outcome of ulcerative colitis patients undergoing pouch surgery is determined by pre-surgical factors.

Yanai H, Ben-Shachar S, Mlynarsky L, Godny L, Leshno M, Tulchinsky H, Dotan I.

Aliment Pharmacol Ther. 2017 Sep;46(5):508-515. doi: 10.1111/apt.14205. Epub 2017 Jun 30.

PMID:
28664992
4.

Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.

Kopylov U, Papamichael K, Katsanos K, Waterman M, Bar-Gil Shitrit A, Boysen T, Portela F, Peixoto A, Szilagyi A, Silva M, Maconi G, Har-Noy O, Bossuyt P, Mantzaris G, Barreiro de Acosta M, Chaparro M, Christodoulou DK, Eliakim R, Rahier JF, Magro F, Drobne D, Ferrante M, Sonnenberg E, Siegmund B, Muls V, Thurm T, Yanai H, Dotan I, Raine T, Levin A, Israeli E, Ghalim F, Carbonnel F, Vermeire S, Ben-Horin S, Roblin X.

Inflamm Bowel Dis. 2017 Sep;23(9):1605-1613. doi: 10.1097/MIB.0000000000001160.

PMID:
28590343
5.

Adolescent transition clinic in inflammatory bowel disease: quantitative assessment of self-efficacy skills.

Yerushalmy-Feler A, Ron Y, Barnea E, Nachum A, Matalon S, Dali-Levy M, Dotan I, Cohen S.

Eur J Gastroenterol Hepatol. 2017 Jul;29(7):831-837. doi: 10.1097/MEG.0000000000000864.

PMID:
28230561
6.

Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn's disease.

Lahat A, Kopylov U, Neuman S, Levhar N, Yablecovitch D, Avidan B, Weiss B, Ben-Horin S, Eliakim R; on behalf of the Israeli IBD research Network (IIRN).

BMC Gastroenterol. 2017 Feb 13;17(1):27. doi: 10.1186/s12876-017-0588-7.

7.

Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience.

Kopylov U, Ron Y, Avni-Biron I, Koslowsky B, Waterman M, Daher S, Ungar B, Yanai H, Maharshak N, Ben-Bassat O, Lichtenstein L, Bar-Gil Shitrit A, Israeli E, Schwartz D, Zittan E, Eliakim R, Chowers Y, Ben-Horin S, Dotan I.

Inflamm Bowel Dis. 2017 Mar;23(3):404-408. doi: 10.1097/MIB.0000000000001039.

PMID:
28178003
8.

Restorative Proctocolectomy in Elderly IBD Patients: A Multicentre Comparative Study on Safety and Efficacy.

Colombo F, Sahami S, de Buck Van Overstraeten A, Tulchinsky H, Mege D, Dotan I, Foschi D, Leo CA, Warusavitarne J, D'Hoore A, Panis Y, Bemelman W, Sampietro GM.

J Crohns Colitis. 2017 Jun 1;11(6):671-679. doi: 10.1093/ecco-jcc/jjw209.

PMID:
27927720
9.

Comparing diagnostic yield of a novel pan-enteric video capsule endoscope with ileocolonoscopy in patients with active Crohn's disease: a feasibility study.

Leighton JA, Helper DJ, Gralnek IM, Dotan I, Fernandez-Urien I, Lahat A, Malik P, Mullin GE, Rosa B.

Gastrointest Endosc. 2017 Jan;85(1):196-205.e1. doi: 10.1016/j.gie.2016.09.009. Epub 2016 Sep 19.

PMID:
27658907
10.

Correction: MicroRNAs Expression in the Ileal Pouch of Patients with Ulcerative Colitis Is Robustly Up-Regulated and Correlates with Disease Phenotypes.

Ben-Shachar S, Yanai H, Sherman Horev H, Elad H, Baram L, Isakov O, Tulchinsky H, Pasmanik-Chor M, Shomron N, Dotan I.

PLoS One. 2016 Oct 18;11(10):e0165220. doi: 10.1371/journal.pone.0165220. eCollection 2016.

11.

Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial.

Dotan I, Levy-Nissenbaum E, Chowers Y, Fich A, Israeli E, Adar T, Shteingart S, Soreq H, Goldin E.

Dig Dis Sci. 2016 Nov;61(11):3246-3254. Epub 2016 Aug 29.

PMID:
27572942
12.

Alterations of Enteric Microbiota in Patients with a Normal Ileal Pouch Are Predictive of Pouchitis.

Maharshak N, Cohen NA, Reshef L, Tulchinsky H, Gophna U, Dotan I.

J Crohns Colitis. 2017 Mar 1;11(3):314-320. doi: 10.1093/ecco-jcc/jjw157.

PMID:
27613294
13.

Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn's disease.

Kopylov U, Klang E, Yablecovitch D, Lahat A, Avidan B, Neuman S, Levhar N, Greener T, Rozendorn N, Beytelman A, Yanai H, Dotan I, Chowers Y, Weiss B, Ben-Horin S, Amitai MM, Eliakim R; Israeli IBD research Nucleus (IIRN).

Therap Adv Gastroenterol. 2016 Sep;9(5):655-63. doi: 10.1177/1756283X16649143. Epub 2016 May 22.

14.

MicroRNAs Expression in the Ileal Pouch of Patients with Ulcerative Colitis Is Robustly Up-Regulated and Correlates with Disease Phenotypes.

Ben-Shachar S, Yanai H, Sherman Horev H, Elad H, Baram L, Issakov O, Tulchinsky H, Pasmanik-Chor M, Shomron N, Dotan I.

PLoS One. 2016 Aug 18;11(8):e0159956. doi: 10.1371/journal.pone.0159956. eCollection 2016. Erratum in: PLoS One. 2016 Oct 18;11(10 ):e0165220.

15.

Prevention of Antidrug Antibody Formation to Infliximab in Crohn's Patients With Prior Failure of Thiopurines.

Bar-Yoseph H, Waterman M, Almog R, Billiet T, Vermeire S, Ungar B, Yanai H, Dotan I, Ben-Horin S, Chowers Y.

Clin Gastroenterol Hepatol. 2017 Jan;15(1):69-75. doi: 10.1016/j.cgh.2016.06.028. Epub 2016 Jul 9.

PMID:
27404966
16.

Magnetic resonance enterography or video capsule endoscopy - what do Crohn's disease patients prefer?

Lahat A, Kopylov U, Amitai MM, Neuman S, Levhar N, Yablecovitch D, Avidan B, Yanai H, Dotan I, Chowers Y, Weiss B, Ben-Horin S, Eliakim R.

Patient Prefer Adherence. 2016 Jun 8;10:1043-50. doi: 10.2147/PPA.S99690. eCollection 2016.

17.

Correction: Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.

Dotan I, Roche PJ, Tamilia M, Paliouras M, Mitmaker EJ, Trifiro MA.

PLoS One. 2016 Jun 16;11(6):e0158022. doi: 10.1371/journal.pone.0158022. eCollection 2016.

18.

Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study.

Danese S, Hart A, Dignass A, Louis E, D'Haens G, Dotan I, Rogler G, D'Agay L, Iannacone C, Peyrin-Biroulet L.

BMJ Open Gastroenterol. 2016 May 17;3(1):e000092. doi: 10.1136/bmjgast-2016-000092. eCollection 2016.

19.

Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis.

Ungar B, Mazor Y, Weisshof R, Yanai H, Ron Y, Goren I, Waizbard A, Yavzori M, Fudim E, Picard O, Loebstein R, Kopylov U, Dotan I, Chowers Y, Eliakim R, Ben-Horin S.

Aliment Pharmacol Ther. 2016 Jun;43(12):1293-9. doi: 10.1111/apt.13631. Epub 2016 Apr 19.

PMID:
27091119
20.

Young GI Angle: What makes for a good mentor?

Dotan I, Burisch J.

United European Gastroenterol J. 2016 Apr;4(2):320. doi: 10.1177/2050640616639520. Epub 2016 Mar 22. No abstract available.

Supplemental Content

Loading ...
Support Center